Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check5 days agoChange DetectedThe Italian location name was updated from Padua, Italy to Padova, Italy in the Locations section. This reflects the native Italian naming of the city.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision v3.5.0 is shown, and revision v3.4.3 is removed.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a new site revision tag (Revision: v3.4.2) and removes the prior 3.4.1 notice; these are minor housekeeping updates that do not affect study data or how users interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operating status was added, with links to cc.nih.gov and opm.gov. The page revision label was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedMinor UI and metadata updates were applied, including showing the glossary and updates to Last Update/Submitted and revision/version labels, with some older labels removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.